TOOLS: What is your favorite biotech stock worth when it’s time for a Big Pharma license deal?

This biotech model generates risk-adjusted values broken down on both licensor and licensee. 💊💉🔬🧬🧪

💊 The template can easily be adapted to raw material exploration projects. Or any risk-adjusted project with heavy investments upfront and revenues far ahead in the future.
 
Also, prints nicely to one horizontal A4.
 
💊 Most biotech R&D companies have no ambition to bring their projects all the way to the market.
 
Instead they target to get through Phase …